Literature DB >> 1480678

Attention, cognition, and motor perseveration in adolescents at genetic risk for schizophrenia and control subjects.

H Schreiber1, G Stolz-Born, H Heinrich, H H Kornhuber, J Born.   

Abstract

Twenty-three offspring of schizophrenic parents (mean age = 12.1 years, SD = 3.2) and 61 adolescent control subjects (mean age = 12.3 years, SD = 3.3) were compared in their performance of the following psychometric tests: simple reaction times (RTs), warned RTs in a monomodal and cross-modal design, d2 concentration test, a motor perseveration test, and a cognitive performance measure (Wechsler Intelligence Scale). The results were validated in a second analysis in which a subgroup of the control subjects were matched to the high-risk subjects for the following characteristics: age, gender, education, and environmental background. Significant deficits were found in the high-risk group in tests that required sustained attention and information processing under high perceptual load (RT measures and d2 concentration test). Deficits were particularly prominent for the processing of visual stimuli; sensory incongruence might also have been a contributor to this deficit. The attentional dysfunction of high-risk subjects might explain their tendency to show less structured behavior and distractibility as reflected by their higher entropy scores in a motor perseveration test. Cognitive evaluation showed a significant deficit in the high-risk group, primarily as reflected in the verbal IQ score.

Entities:  

Mesh:

Year:  1992        PMID: 1480678     DOI: 10.1016/0165-1781(92)90047-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

Review 1.  Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review.

Authors:  Jessica Agnew-Blais; Larry J Seidman
Journal:  Cogn Neuropsychiatry       Date:  2012-09-21       Impact factor: 1.871

2.  Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies.

Authors:  Larry J Seidman; Anthony J Giuliano; Christopher W Smith; William S Stone; Stephen J Glatt; Eric Meyer; Stephen V Faraone; Ming T Tsuang; Barbara Cornblatt
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

3.  Response selection in schizophrenia.

Authors:  Giuseppe Pellizzer; Massoud Stephane
Journal:  Exp Brain Res       Date:  2007-02-20       Impact factor: 1.972

Review 4.  Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk.

Authors:  A L Wolff; G A O'Driscoll
Journal:  J Psychiatry Neurosci       Date:  1999-09       Impact factor: 6.186

5.  Cognitive reserve and its correlates in child and adolescent offspring of patients diagnosed with schizophrenia or bipolar disorder.

Authors:  Josefina Castro-Fornieles; Elena de la Serna; Patricia Camprodon-Boadas; Mireia Rosa-Justicia; Gisela Sugranyes; Dolores Moreno; Inmaculada Baeza; Daniel Ilzarbe; Covadonga Martínez Díaz-Caneja; Mirian Ayora; Jessica Merchan; Nuria Martín; Roger Borras; Clemente García-Rizo; Carla Torrent
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-02-17       Impact factor: 4.785

6.  Abnormal pitch mismatch negativity in individuals with schizotypal personality disorder.

Authors:  Margaret A Niznikiewicz; Kevin M Spencer; Chandlee Dickey; Martina Voglmaier; Larry J Seidman; Martha E Shenton; Robert W McCarley
Journal:  Schizophr Res       Date:  2009-03-27       Impact factor: 4.939

7.  Psychopathology in children of schizophrenics.

Authors:  Sharita Shah; Sanjeev Kamat; Urmila Sawant; H S Dhavale
Journal:  Indian J Psychiatry       Date:  2003-04       Impact factor: 1.759

8.  Impaired working speed and executive functions as frontal lobe dysfunctions in young first-degree relatives of schizophrenic patients.

Authors:  Silke Klemm; Beate Schmidt; Susanne Knappe; Bernhard Blanz
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-05-23       Impact factor: 4.785

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.